Who owns BioNTech SE?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of BNTX from SEC Form 13F filings across 280 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 280 institutions disclosed 46.9M shares of BioNTech SE worth $4.78B — about 18.5% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
280
13F holders
$4.78B
value, 2026 filers
18.5%
of shares outstanding (46.9M sh)
43
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of BNTX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 7.6M | $704.6M | 0.0% | 3% | +32.6% |
| 2 | PRIMECAP MANAGEMENT CO/CA/ | 3.8M | $351.0M | 0.2% | 1.5% | -0.6% |
| 3 | Dodge & Cox | 3.7M | $342.2M | 0.2% | 1.5% | 0.0% |
| 4 | FLOSSBACH VON STORCH SE | 2.2M | $207.1M | 0.9% | 0.9% | -39.5% |
| 5 | T. Rowe Price Investment Management, Inc. | 2.1M | $192.2M | 0.1% | 0.8% | -64.7% |
| 6 | BlackRock, Inc. | 1.9M | $172.6M | 0.0% | 0.7% | +11.9% |
| 7 | Temasek Holdings (Private) Ltd | 1.5M | $140.1M | 0.4% | 0.6% | 0.0% |
| 8 | BNP PARIBAS FINANCIAL MARKETS | 1.3M | $122.8M | 0.0% | 0.5% | -20.1% |
| 9 | Logos Global Management LPNEW | 1.0M | $94.4M | 4.1% | 0.4% | new |
| 10 | GSK plc | 889,824 | $82.8M | 13.7% | 0.4% | 0.0% |
| 11 | FIRST TRUST ADVISORS LP | 791,469 | $73.6M | 0.0% | 0.3% | -5.8% |
| 12 | Davern Capital Partners, LP | 754,550 | $70.2M | 12.0% | 0.3% | +147.3% |
| 13 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 744,200 | $69.2M | 0.0% | 0.3% | -5.1% |
| 14 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 677,708 | $63.1M | 0.0% | 0.3% | +1.1% |
| 15 | Long Focus Capital Management, LLC | 624,000 | $58.1M | 1.5% | 0.2% | 0.0% |
| 16 | BAILLIE GIFFORD & CO | 592,380 | $55.1M | 0.1% | 0.2% | -32.9% |
| 17 | GOLDMAN SACHS GROUP INC | 589,903 | $54.9M | 0.0% | 0.2% | +509.2% |
| 18 | VICTORY CAPITAL MANAGEMENT INC | 539,787 | $50.2M | 0.0% | 0.2% | +13.2% |
| 19 | FRANKLIN RESOURCES INC | 539,593 | $50.2M | 0.0% | 0.2% | +40.3% |
| 20 | Candriam S.C.A. | 497,530 | $46.3M | 0.2% | 0.2% | +1.9% |
| 21 | MORGAN STANLEY | 492,092 | $45.8M | 0.0% | 0.2% | +2.0% |
| 22 | BANK OF AMERICA CORP /DE/ | 486,205 | $45.2M | 0.0% | 0.2% | -46.2% |
| 23 | DekaBank Deutsche Girozentrale | 481,397 | $41.2M | 0.1% | 0.2% | 0.0% |
| 24 | TANG CAPITAL MANAGEMENT LLC | 470,000 | $43.7M | 2.0% | 0.2% | 0.0% |
| 25 | Balyasny Asset Management L.P. | 463,163 | $43.1M | 0.1% | 0.2% | +395.6% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.